| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $398K | -62.2% |
| Cost of Revenue | $388K | -59.5% |
| Gross Profit | $10K | -89.1% |
| R&D Expense | $1.4M | -0.4% |
| SG&A Expense | $2.1M | +21.5% |
| Operating Income | -$6.2M | -24.9% |
| Income Tax | $0 | — |
| Net Income | -$3.2M | +32.2% |
| EPS (Basic) | -$0.48 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $6K | -96.6% |
| Inventory | $126K | -55.3% |
| Current Assets | $3.8M | +274.1% |
| Total Assets | $4.1M | -23.5% |
| Current Liabilities | $877K | -47.1% |
| Total Liabilities | $885K | -50.5% |
| Stockholders' Equity | $3.2M | -9.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.7M | -32.0% |
| Capital Expenditures | $19K | -9.4% |
| Investing Cash Flow | $7.1M | — |
| Financing Cash Flow | $706K | +262.7% |
| Free Cash Flow | -$4.7M | -31.7% |
| -500.0% |
| EPS (Diluted) | -$0.48 | -500.0% |